-
NuVasive's Pulse surpasses 500 cases; robotics will be a 'key application'
NuVasive's Pulse integrated spine surgery system was a key growth driver in the first quarter and has been used in more than 500 commercial cases, the company said in its first-quarter earnings call May 4, according to Seeking Alpha. -
Stryker promotes new board leadership
Stryker promoted two members of its board of directors to leadership positions. -
NuVasive posts 7.2% revenue increase in Q1: 4 notes
NuVasive on May 4 posted revenue growth in the first quarter of 2022 and almost $20 million in net profit. -
Wenzel Spine names CEO, SeaSpine's new leadership and more: 9 device company notes
Camber Spine's latest patent and eight more updates from spine and orthopedic devicemakers in the last week: -
SeaSpine sees 21% revenue jump in Q1, names new leadership
SeaSpine's first-quarter sales grew across its spinal implants and orthobiologics, and the company named new leadership. -
4 technologies exciting spine surgeons
Innovation continues to pick up steam across the spine industry as surgeons look for more minimally invasive methods to operate on their patients, reduce the risk of complications and accelerate recovery. -
New leadership steps in at Wenzel Spine after former CEO's death
Wenzel Spine appointed William Wilson as CEO almost two months after the devicemaker's former CEO died. -
Spine devicemaker's partnership aims to improve reimbursement
Genesys Spine is partnering with Pria Healthcare to improve patient coverage for its sacroiliac joint fusion products. -
Devicemaker launches spine surgical access system
Spine devicemaker TeDan Surgical released a surgical access system designed for anterior approaches. -
Smith+Nephew has 'encouraging start' to 2022, sports medicine grows 10% in Q1
Smith+Nephew saw a slight revenue uptick in the first quarter of 2022; however, its sports medicine and joint repair segment jumped with double-digit growth. -
Who is Globus Medical's new CEO? 5 things to know
Daniel Scavilla is the new CEO of Globus Medical, succeeding Dave Demski, who stepped down to pursue other opportunities after 20 years with the company. -
Stryker's spine, orthopedic sales grow 5.1% in Q1: 5 notes
Stryker on April 28 posted $4.3 billion in first-quarter net sales and saw 5.1 percent growth in its orthopedics and spine business. -
Camber Spine snags 47th patent allowance
Camber Spine received a notice of allowance from the U.S. Patent and Trademark Office for its Variant Retractor. -
10 devices receiving patents since 2020
The U.S. Patent and Trademark Office has granted patents to multiple innovative spine and orthopedic devices since 2020. -
Globus Medical CEO shift, new artificial disc data and more: 8 medtech notes
A milestone in an artificial disc trial and seven more updates from spine and orthopedic device companies in the last week: -
Lumbar interbody fusion device design gets US patent
CTL Amedica was recently granted a U.S. patent for its Klimt expandable lumbar interbody fusion cage design. -
Bioventus to sell $415M in senior notes
Bioventus intends to sell $415 million worth of senior notes in a private offering. -
Medtronic appoints chief scientific, medical and regulatory officer
Medtronic promoted Laura Mauri, MD, to serve as chief scientific, medical, and regulatory officer April 25. -
Dr. Kevin McGuire debuts Medacta screw system with AR technology
The first case with Medacta's MUST pedicle screw system and NextAR system was completed by Kevin McGuire, MD. -
C-suite shifts: 8 medtech appointments to know in 2022
Spine and orthopedic devicemakers have made changes in their top leadership roles in 2022.
Page 44 of 197